Evercyte and TAmiRNA to highlight advances in EV characterization at Precision EV forum

We, together with our partner TAmiRNA, will join the upcoming Precision EV Forum in Cambridge, UK. As key players in the EVscale™ platform, we will highlight our innovations in extracellular vesicle (EV) therapeutics and production.

Evercyte’s extensive portfolio of clinical-grade EVs, produced from telomerized MSCs derived from various tissues, is our focal point. These advanced EVs are critical to the development of new therapeutic applications allowing for faster, scalable and sustainable continuous EV manufacturing.

Check out our EV production cell lines, EV products and EV services.